Protease-activated Receptor-2 (PAR2) in Human Periodontitis

被引:33
|
作者
Holzhausen, M. [1 ]
Cortelli, J. R. [1 ]
Araujo da Silva, V. [1 ]
Nobre Franco, G. C. [1 ]
Cavalca Cortelli, S. [1 ]
Vergnolle, N. [2 ,3 ]
机构
[1] Univ Sao Paulo, Dept Stomatol, Sch Dent, Div Periodont, BR-05508000 Sao Paulo, Brazil
[2] Ctr Physiopathol Toulouse Purpan, INSERM, U563, F-31300 Toulouse, France
[3] Univ Toulouse 3, F-31000 Toulouse, France
基金
巴西圣保罗研究基金会;
关键词
periodontal disease; protease-activated receptor-2; Porphyromonas gingivalis; ORAL EPITHELIAL-CELLS; UP-REGULATION; EXPRESSION; INFLAMMATION; PROTEASE-ACTIVATED-RECEPTOR-2; ARTHRITIS; PAIN; PROTEINASE-ACTIVATED-RECEPTOR-2; PROTEINASES; INFECTION;
D O I
10.1177/0022034510373765
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
No evidence for the role of protease-activated receptor-2 (PAR(2)) in human periodontal disease has been demonstrated so far. Thus, we sought to investigate the expression of PAR(2) mRNA in chronic periodontitis, and to examine whether its expression is related to the presence of PAR(2) potential activators. Microbiological and gingival crevicular fluid samples were collected from individuals with chronic periodontitis and control individuals, and the presence of neutrophil serine proteinase 3 (P3) and Porphyromonas gingivalis was evaluated. PAR(2) mRNA expression was higher (p < 0.001) in those with chronic periodontitis compared with control individuals, and it was statistically decreased (p = 0.0006) after periodontal treatment. Furthermore, those with chronic periodontitis presented higher (p < 0.05) levels of IL-1 alpha, IL-6, IL-8, and TNF-alpha, total proteolytic activity, P. gingivalis prevalence, and P3mRNA expression compared with control individuals. We conclude that PAR(2) mRNA expression and its potential activators are elevated in human chronic periodontitis, therefore suggesting that PAR(2) may play a role in periodontal inflammation.
引用
收藏
页码:948 / 953
页数:6
相关论文
共 50 条
  • [1] Protease-activated receptor-2 (PAR2) in the airways
    Cocks, TM
    Moffatt, JD
    [J]. PULMONARY PHARMACOLOGY & THERAPEUTICS, 2001, 14 (03) : 183 - 191
  • [2] Protease-activated receptor-2 (PAR2) in cardiovascular system
    Bucci, M
    Roviezzo, F
    Cirino, G
    [J]. VASCULAR PHARMACOLOGY, 2005, 43 (04) : 247 - 253
  • [3] Does protease-activated receptor-2 (PAR2) influence muscle development and regeneration?
    Esfandouni, N. Taghavi
    Mackie, E.
    Pagel, C.
    [J]. NEUROMUSCULAR DISORDERS, 2015, 25 : S218 - S219
  • [4] Predictive value of protease-activated receptor-2 (PAR2) in cervical cancer metastasis
    He, Shengnan
    Xu, Meiquan
    Xiong, Zhen
    Hu, Ye
    Huo, Qin
    Lu, Jingxiao
    Lin, Yuntao
    Yang, Lan
    [J]. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2021, 25 (03) : 1415 - 1424
  • [5] Toward Drugs for Protease-Activated Receptor 2 (PAR2)
    Yau, Mei-Kwan
    Liu, Ligong
    Fairlie, David P.
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (19) : 7477 - 7497
  • [6] Protease-Activated Receptor-2 (PAR2)-A Novel Therapeutic Target in Nonalcoholic Steatohepatitis (NASH)
    Shearer, Andrew M.
    Austin, Karyn
    Guha, Srijoy
    Nga Nguyen
    Looby, Richard
    Clappin, Allyson
    Baleja, James
    Covic, Lidija
    Kuliopulos, Athan
    [J]. HEPATOLOGY, 2014, 60 : 587A - 587A
  • [7] Pepducin - A Novel Protease-Activated Receptor-2 (par2) Inhibitor - Attenuates Experimental Pulmonary Hypertension
    Warburton, R.
    Kuliopulos, A.
    Wieschhaus, A.
    Kayyali, U. S.
    Toksoz, D.
    Fanburg, B. L.
    Preston, I. R.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [8] Protease activated receptor-2 (PAR2): possible target of phytochemicals
    Kakarala, Kavita Kumari
    Jamil, Kaiser
    [J]. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2015, 33 (09): : 2003 - 2022
  • [9] Protease-Activated Receptor-2 (PAR2) in Human Gastric Mucosa as Mediator of Proinflammatory Effects in Helicobacter pylori Infection
    Kandulski, Arne
    Kuester, Doerthe
    Moenkemueller, Klaus
    Fry, Lucia
    Malfertheiner, Peter
    Wex, Thomas
    [J]. HELICOBACTER, 2011, 16 (06) : 452 - 458
  • [10] Targeting Liver Fibrosis with a Cell-penetrating Protease-activated Receptor-2 (PAR2) Pepducin
    Shearer, Andrew M.
    Rana, Rajashree
    Austin, Karyn
    Baleja, James D.
    Nguyen, Nga
    Bohm, Andrew
    Covic, Lidija
    Kuliopulos, Athan
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2016, 291 (44) : 23188 - 23198